Description
Only FDA-cleared self-balancing exoskeleton (no crutches required); 12 actuated DOF (hip/knee/ankle); FDA expanded clearance for MS in 2025; deployed in 100+ US hospitals; raised $75M Series D June 2025.
Use cases
- SCI
- Stroke
- MS patients (clinical rehabilitation)
Specifications
- Power type
- Active
- Body region
- Lower-limb
- Weight
- 75.00 kg
- Launch year
- 2020
- Country of origin
- FR
- Battery life
- 2.0 hrs
- Certifications
- FDA, CE